Simeon Margolis, MD, PhD

Size: px
Start display at page:

Download "Simeon Margolis, MD, PhD"

Transcription

1 Simeon Margolis, MD, PhD Decisions on when to lower LDL cholesterol are based on a combination of risk status and the LDL cholesterol Cigarette smoking Hypertension HDL cholesterol <40 mg/ml Age (men > 45, women >55) Family history of premature coronary artery disease Male 1 st degree relative <55 Female 1 st degree relative <65 HDL cholesterol >60 is a negative risk factor Coronary heart disease Peripheral arterial disease Abdominal aortic aneurysm Symptomatic carotid artery disease Diabetes mellitus Multiple risk factors that confer > 20% risk of a coronary event in the next 10 years Risk category LDL-ch goal Zero to one risk factor <160 Two or more risk factors <130 High risk <100 (CHD or CHD equivalents) Very high risk (CHD+) <70 1

2 Lipoprotein Major component CHD risk VLDL Triglycerides Increased LDL Cholesterol Increased Lower total and LDL cholesterol Lower triglycerides Raise HDL cholesterol HDL Protein Decreased Proper diet Weight loss Exercise <10% of energy intake from saturated fat <7% of energy intake if LDL needs to be lowered Dietary cholesterol intake <300 mg/day <200 mg/d if LDL needs to be lowered Increase soluble fiber and plant stanol/sterol esters Unsaturated fat: unsaturated ~10% of energy intake monounsaturated preferred eat fish at least 2 times a week if coronary disease known, take fish oil supplements Minimize intake of trans fatty acids WEIGHT LOSS Supplements of omega-3 fatty acids Patients with triglycerides > 500 mg/dl need fat restriction and medications. 2

3 Weight loss Exercise Moderate alcohol intake Patients fail to comply with diet. Diet doesn t lower lipids enough. Drug Statins Bile acid sequestrants Ezetimibe Niacin Fibrates Mechanism Inhibit cholesterol synthesis Inhibit bile acid reabsorption Inhibits cholesterol absorption Inhibits VLDL synthesis Speed conversion of VLDL to LDL Statins - first choice Add-on drugs to achieve LDL-Ch, TG, or HDL-Ch goals Major use: Lower LDL cholesterol Lipid/lipoprotein effects: Lower LDL-Ch up to 60% Raise HDL-Ch 8 to 10% Lower triglycerides 10 to 30% Contraindications: Active liver disease Rosuvastatin Pitavastatin Atorvastatin Simvastatin* Pravastatin* = lovastatin* Fluvastatin * Indicates off-patent 3

4 Muscle pain Ask about muscle pain and weakness Myositis : symptoms + elevated CK Rhabdomyolysis and renal failure Permanent liver damage never reported Stop statin and measure CK If CK < 1000, restart same stain when muscle pain is no longer present If muscle pain recurs, Try different statins Low dose or less frequent dose Baseline LFT s only Follow-up LFTs not needed CP if muscle pain or weakness Fibrates especially gemfibrozil Macrolide antibiotics Erythromycin Clarithromycin Rifampin Azole antifungals Calcium channel blockers Amiodarone Cyclosporin Failure to start drug at hospital discharge Poor patient compliance Failure of physicians to monitor compliance Inadequate dose of medication Blocks absorption of dietary and biliary cholesterol Lowers LDL cholesterol by about 15% Useful in combination with statin (Vytorin) Few side effects 4

5 Major use: Lower LDL-ch Lipid/lipoprotein effects: Lower LDL-ch 10 to 25% Raise HDL-ch 1 to 3% Triglycerides: increase or no change Contraindications: Elevated triglycerides Major adverse effects: Gastrointestinal symptoms, decreased absorption of some drugs, elevated liver transaminases Cholestyramine (Questran) Colestipol (Colestid) Colesevelam (WelChol) Increase triglycerides Absolute contraindication TGs > 400 mg/dl Relative contraindication TG mg/dl Decreased absorption of anionic drugs and vitamins Not a problem with colesevelam Bloating, constipation, even bowel obstruction Taurine 500 mg may decrease constipation Classification Normal Borderline high High Very high Serum Level <150 mg/dl mg/dl mg/dl >500 mg/dl Goal: Prevent pancreatitis Very low fat diet (<15% of calories) TG-lowering drug usually required Reduce TG before lowering LDL-Ch 5

6 Primary target: lower LDL cholesterol Secondary target: Non-HDL cholesterol Achieve LDL goal with statins before treating non-hdl cholesterol Non-HDL-Ch = Total Ch HDL-Ch Non-HDL-Ch includes atherogenic VLDL and chylomicron remnants Non HDL-Ch goal = LDL-Ch goal + 30 mg/dl May predict CHD risk better than LDL-Ch By 20 to 50% Fibrates: gemfibrozil, fenofibrate Niacin Omega-3 fish oil Over-the counter Prescription By 7 to 25% Statins Lower triglycerides 20 to 50% Lower non-hdl-ch 12 to 18% Raise HDL-Ch 8 to 10% Lower total Ch 8 to 12 % But May raise LDL-Ch Use with caution: Gemfibrozil with statin, renal insufficiency Major adverse effects: GI symptoms, elevated liver transaminases, myositis with statins Dyspepsia Gallstones Elevated LFTs Venous thrombosis and pulmonary emboli Prothrombin time raised with warfarin Rx Reduce warfarin dose Lower dose in patients with impaired renal function Avoid gemfibrozil with statins Epidemiologic studies have shown that elevated triglycerides and low HDL-Ch are independent risk factors for coronary heart disease. BUT little proof that lowering triglycerides or raising HDL-Ch reduces CHD events 6

7 Two studies have shown a significant reduction in coronary events with gemfibrozil treatment. Helsinki Heart Study VA/HIT Study Niacin is most effective Fibrates and statins raise HDL cholesterol by about 8% to 10% Estrogens after the menopause Lower LDL-Ch 10 to 25% Raise HDL-Ch 15 to 35% Lower triglycerides 20 to 50% Flushing, itching, redness Liver toxicity Dyspepsia, nausea, vomiting Increased uric acid levels and gout Slight rise in fasting glucose and HbA1c Liver disease History of peptic ulcer or GI bleed Gout Start with low niacin dose Less flushing with extended-release niacin Flushing worsened with hot beverages, spicy foods, alcohol, hot showers Aspirin or other NSAIDs 30 to 60 min before niacin dose Flushing diminishes over time with consistent dosing 7

8 Immediate release - crystalline niacin Sustained (Slow) release Extended release (Niaspan) Immediate release no cases with < 3 g Extended release 2 g 0/223 subjects Sustained releases 1.5 to 3g 12/223 Reports of severe liver toxicity DON T use sustained release Drug Cholesterol Triglycerides HDL-CH Bile acid sequestrants -or - Niacin Statins Fibrates Ezetimibe - - 8

High Blood Cholesterol

High Blood Cholesterol National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour

More information

NCEP Drug Treatment. Major Classes of Drugs Available Affecting Lipoprotein Metabolism

NCEP Drug Treatment. Major Classes of Drugs Available Affecting Lipoprotein Metabolism Major Classes of Drugs Available Affecting Lipoprotein Metabolism HMG CoA reductase inhibitors lovastatin, pravastatin, simvastatin, fluvastatin, atorvastatin cholestyramine, colestipol, colesevelam crystalline,

More information

Cholesterol and Triglycerides What You Should Know

Cholesterol and Triglycerides What You Should Know Cholesterol and Triglycerides What You Should Know Michael T. McDermott MD Professor of Medicine Endocrinology Practice Director Division of Endocrinology, Metabolism and Diabetes University of Colorado

More information

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Primary Care Management of Women with Hyperlipidemia Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Objectives: Define dyslipidemia in women Discuss the investigation process leading

More information

Guidelines for the management of dyslipidaemia in patients with diabetes mellitus

Guidelines for the management of dyslipidaemia in patients with diabetes mellitus Guidelines for the management of dyslipidaemia in patients with diabetes mellitus Quick reference guide More than 60% of type 2 diabetic subjects in the Eastern Mediterranean Region have some degree of

More information

Treating High Cholesterol. A Guide for Adults

Treating High Cholesterol. A Guide for Adults Treating High Cholesterol A Guide for Adults Fast Facts n n n n n n High cholesterol can lead to heart attacks and strokes. There are different kinds of medicines to treat high cholesterol. Medicines called

More information

FORTH VALLEY. LIPID LOWERING GUIDELINES v4 May 2010

FORTH VALLEY. LIPID LOWERING GUIDELINES v4 May 2010 FORTH VALLEY LIPID LOWERING GUIDELINES v4 May 2010 This guideline applies to people over 16 years of age. This guideline is not intended to serve as a standard of medical care or be applicable in every

More information

THE THIRD REPORT OF THE EXpert

THE THIRD REPORT OF THE EXpert SPECIAL COMMUNICATION Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

More information

Leading cause of death for men and women. Coronary heart disease (CHD) most common. Diet Physical inactivity Obesity Alcohol

Leading cause of death for men and women. Coronary heart disease (CHD) most common. Diet Physical inactivity Obesity Alcohol CHOLESTEROL AND STATINS HEART DISEASE Leading cause of death for men and women Coronary heart disease (CHD) most common Terri Giordano MSN, CRNP, CORLN The Children s Hospital of Philadelphia Division

More information

Lower LDL Cholesterol

Lower LDL Cholesterol Key #6 Lower LDL Cholesterol Understanding LDL Cholesterol LDL stands for low-density lipoproteins. Lipoproteins are molecules that carry fats around the body. LDL is sometimes referred to as lousy or

More information

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181

More information

CHOLESTEROL 101: WHAT YOU NEED TO KNOW TO KEEP YOUR HEART HEALTHY. By: Camille Quiles, PharmD., RPh.

CHOLESTEROL 101: WHAT YOU NEED TO KNOW TO KEEP YOUR HEART HEALTHY. By: Camille Quiles, PharmD., RPh. CHOLESTEROL 101: WHAT YOU NEED TO KNOW TO KEEP YOUR HEART HEALTHY By: Camille Quiles, PharmD., RPh. WHAT IS CHOLESTEROL? CHOLESTEROL Waxy, fat-like substance found in all cells of the body Your body uses

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

Managing Dyslipidemias in Patients With Chronic Kidney Disease

Managing Dyslipidemias in Patients With Chronic Kidney Disease Managing Dyslipidemias in Patients With Chronic Kidney Disease Causes of Death Among Period Prevalent Patients, 1997-1999, Treated with Hemodialysis, Peritoneal Dialysis or Kidney Transplantation Abbreviations:

More information

Hypercholesterolemia

Hypercholesterolemia Hypercholesterolemia Hypercholesterolemia, or high cholesterol, occurs when there is too much cholesterol in the body. Cholesterol is a soft, waxy, fat-like substance that is a natural component of all

More information

Education. Panel. Triglycerides & HDL-C

Education. Panel. Triglycerides & HDL-C Triglycerides & HDL-C Thomas Dayspring, MD, ACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey Attending in Medicine: St Joseph s s Hospital, Paterson, NJ Certified

More information

An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia

An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates

More information

Omega-3 Fatty Acid Products

Omega-3 Fatty Acid Products Omega-3 Fatty Acid Products Policy Number: 5.01.563 Last Review: 7/2016 Origination: 6/2014 Next Review: 7/2017 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for the

More information

Cholesterol - New Guidelines and Treatment Protocols

Cholesterol - New Guidelines and Treatment Protocols Cholesterol - New Guidelines and Treatment Protocols By: James L. Holly, MD The New Year brings new opportunities to improve our health. Many of us receive gifts which we can't use because there's too

More information

Oxfordshire CCG Lipid Management Guidance Updated April Inside this issue: guidelines.

Oxfordshire CCG Lipid Management Guidance Updated April Inside this issue: guidelines. Prescribing Points A NEWSLETTER FOR ALL HEALTH CARE PROFESSIONALS IN OXFORDSHIRE, WRITTEN BY THE MEDICINES MANAGEMENT TEAM, OXFORDSHIRE CCG, JUBILEE HOUSE, OXFORD BUSINESS PARK SOUTH, OXFORD, OX4 2LH.

More information

Understanding and Controlling Cholesterol MKMG MOUNT KISCO MEDICAL GROUP. Michael S.Wein, MD. Katonah Office (914)

Understanding and Controlling Cholesterol MKMG MOUNT KISCO MEDICAL GROUP. Michael S.Wein, MD. Katonah Office (914) Understanding and Controlling Cholesterol MKMG MOUNT KISCO MEDICAL GROUP Michael S.Wein, MD Katonah Office (914) 232-3135 Disclaimers, disclosures, conflicts of interest, etc Absolutely none Tonight s

More information

First step: determine the goal for dyslipidemia treatment (primary prevention vs. secondary prevention)

First step: determine the goal for dyslipidemia treatment (primary prevention vs. secondary prevention) The American college of cardiology (ACC) and American Heart Association (AHA) in combination with National Heart, Lung and blood institute (NHLBI) have released 4 new guidelines. At the invitation of the

More information

Very High Triglycerides

Very High Triglycerides Understanding Very High Triglycerides For more information, visit CardioSmart.org/VHTG Understanding Very High Triglycerides Keeping track of your cholesterol is a very good idea. That s also true for

More information

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING

More information

Understanding and Managing Your. Triglycerides

Understanding and Managing Your. Triglycerides Understanding and Managing Your Triglycerides What are Triglycerides? There are several types are one of several types of fat in your body, and triglycerides are the most common. Along with LDL ( bad )

More information

Statins for Hyperlipidemia (High Cholesterol)

Statins for Hyperlipidemia (High Cholesterol) Statins for Hyperlipidemia (High Cholesterol) Examples of statin drugs Brand Name Mevacor Pravachol Zocor Lescol, Lescol XL Lipitor Crestor Chemical Name lovastatin pravastatin sodium simvastatin fluvastatin

More information

What You Need to Know about High Blood Cholesterol

What You Need to Know about High Blood Cholesterol What You Need to Know about High Blood Why is high cholesterol bad? is a natural substance found in our diet and made by our liver. It is important for many functions throughout our body. High blood cholesterol

More information

REACH Risk Evaluation to Achieve Cardiovascular Health

REACH Risk Evaluation to Achieve Cardiovascular Health Dyslipidemia and obesity History: A 13-year-old girl is seen for a routine clinic follow-up visit. She has been previously healthy, but her growth curve shows increasing body mass index (BMI) percentiles

More information

What is high cholesterol?

What is high cholesterol? Statin medicines This brochure gives you information on high cholesterol and the medicines most commonly used to manage it. You ll learn how these medicines compare and get important information about

More information

Anti-Atheroscrerotic Drugs

Anti-Atheroscrerotic Drugs Anti-Atheroscrerotic Drugs Masuko Ushio-Fukai, PhD, FAHA Dept. of Pharmacology University of Illinois at Chicago Anti-Atherogenic Drugs: Treatment of Hyperlipidemias Knowledge Objectives: 1) Know the mechanism

More information

Cardiovascular Risk and Dyslipidemia Management Clinician Guide MAY 2015

Cardiovascular Risk and Dyslipidemia Management Clinician Guide MAY 2015 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Cardiovascular Risk and Dyslipidemia Management Clinician Guide MAY 2015 Introduction This Clinician Guide was developed to assist Primary Care physicians

More information

High Blood Cholesterol What you need to know

High Blood Cholesterol What you need to know National Cholesterol Education Program High Blood Cholesterol What you need to know Why Is Cholesterol Important? Your blood cholesterol level has a lot to do with your chances of getting heart disease.

More information

Triglycerides are an important measure of heart health. Here's why triglycerides matter and what to do if your triglycerides are too high.

Triglycerides are an important measure of heart health. Here's why triglycerides matter and what to do if your triglycerides are too high. Diseases and Conditions High cholesterol Triglycerides are an important measure of heart health. Here's why triglycerides matter and what to do if your triglycerides are too high. By Mayo Clinic Staff

More information

Case Based Lipid Management by the Guidelines

Case Based Lipid Management by the Guidelines Case Based Lipid Management by the Guidelines Jeffrey Michel, MD FACC Senior Staff Cardiologist Baylor Scott and White Healthcare Jeffrey.Michel@BSWHealth.org How to prescribe Statins for primary prevention

More information

Atherosclerosis Timeline

Atherosclerosis Timeline Atherosclerosis Timeline Foam Cells Fatty Streak Intermediate Lesion Atheroma Fibrous Plaque Plaque Rupture Cholesterol Accumulation - Inflammation Decades Modified from Stary HC et al, Circulation 92:1355,

More information

ROSUVASTATIN RATIOPHARM Date: 5/2016, Version: 3.0

ROSUVASTATIN RATIOPHARM Date: 5/2016, Version: 3.0 ROSUVASTATIN RATIOPHARM Date: 5/2016, Version: 3.0 VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Familial hypercholesterolemia (FH) is a genetic disorder characterized by high

More information

Nutrition: Knowing Your Total Cholesterol

Nutrition: Knowing Your Total Cholesterol Nutrition: Knowing Your Total Cholesterol A number of factors can increase your risk for coronary heart disease. To make an accurate assessment your doctor will determine your lipid profile, overall health,

More information

High Cholesterol (Hyperlipidemia)

High Cholesterol (Hyperlipidemia) High Cholesterol (Hyperlipidemia) My cholesterol medication is: The directions are: In recent years, powerful new drugs have been developed to reduce cholesterol in your blood, thereby reducing your risk

More information

Cholesterol and Human Health

Cholesterol and Human Health Cholesterol and Human Health Hongbao Ma Department of Medicine, Michigan State University, East Lansing, Michigan 48824, USA hongbao@msu.edu, (517) 432-0623 Abstract: Cholesterol plays a major role in

More information

To describe different types of cholesterol and their metabolism. To recognize when to treat in different age groups

To describe different types of cholesterol and their metabolism. To recognize when to treat in different age groups To describe different types of cholesterol and their metabolism To identify when to start screening To recognize when to treat in different age groups To list the treatment goals and different treatment

More information

High Cholesterol and Heart Disease

High Cholesterol and Heart Disease Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................

More information

NEW GUIDELINES FOR CHOLESTEROL MANAGEMENT: WHAT HAS CHANGED? LAUREN HYNICKA, PHARMD, BCPS MOHAMED SARG, PHARMD, BCPS

NEW GUIDELINES FOR CHOLESTEROL MANAGEMENT: WHAT HAS CHANGED? LAUREN HYNICKA, PHARMD, BCPS MOHAMED SARG, PHARMD, BCPS NEW GUIDELINES FOR CHOLESTEROL MANAGEMENT: WHAT HAS CHANGED? LAUREN HYNICKA, PHARMD, BCPS MOHAMED SARG, PHARMD, BCPS NEW GUIDELINES FOR CHOLESTEROL MANAGEMENT: WHAT HAS CHANGED? ACTIVITY DESCRIPTION Cholesterol

More information

Cholesterol Drugs * and Adverse Events Study Questionnaire

Cholesterol Drugs * and Adverse Events Study Questionnaire Cholesterol Drugs * and Adverse Events Study Questionnaire ---This data will be used for research purposes only. Your personal information will not be released.--- Personal profile: Last Name: Today s

More information

Welchol (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes

Welchol (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)

More information

Dyslipidemia and Coronary Artery Disease Risk Assessment and Prevention

Dyslipidemia and Coronary Artery Disease Risk Assessment and Prevention Dyslipidemia and Coronary Artery Disease Risk Assessment and Prevention June 12, 2011 Raul J Seballos, MD, FACP Vice Chair, Preventive Medicine seballr@ccf.org Question #1 55 yo man with a history of

More information

Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).

Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Complete Summary GUIDELINE TITLE (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment

More information

How to manage your CHOLESTEROL. Heart and Stroke Foundation

How to manage your CHOLESTEROL. Heart and Stroke Foundation How to manage your CHOLESTEROL Heart and Stroke Foundation 1 Why Blood Cholesterol Matters High blood cholesterol is one of the major controllable risk factors for coronary heart disease, heart attack

More information

PATHOGENESIS OF HYPERLIPOPROTEINAEMIAS

PATHOGENESIS OF HYPERLIPOPROTEINAEMIAS PATHOGENESIS OF HYPERLIPOPROTEINAEMIAS G.D. Gupta, Atu1 Jain & A.Y. Deshmukh There are two ways to define normal levels of lipoproteins l : i) Serum cholesterol value above the 95th percentile for a given

More information

Preventing Heart Disease

Preventing Heart Disease Preventing Heart Disease Debra Krummel, PhD, RDN, FAND 3/4/16 1 Risk Factors Modifiable Dyslipidemia High LDL-C Low HDL-C Elevated triglycerides Hypertension Diabetes Obesity Dietary factors Sedentary

More information

Metabolic Diseases: Obesity, Hyperlipidemia, and Diabetes

Metabolic Diseases: Obesity, Hyperlipidemia, and Diabetes Metabolic Diseases: Obesity, Hyperlipidemia, and Diabetes Obesity Approximately 1 in 3 adults are overweight in the U.S. Arizona According to CDC, Arizona has highest reported percentage of adults who

More information

High Blood Cholesterol

High Blood Cholesterol National Cholesterol Education Program High Blood Cholesterol Detection Evaluation Treatment Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and

More information

Vitamins, Supplements and Heart Disease

Vitamins, Supplements and Heart Disease Vitamins, Supplements and Heart Disease Daniel J. O Rourke, MD, MS Chief of Cardiology, WRJ Veterans Affairs Staff Cardiologist, Dartmouth-Hitchcock Medical Center JACC 2005;46:184-221 Scope of Use In

More information

Taking a statin to reduce the risk of coronary heart disease and stroke

Taking a statin to reduce the risk of coronary heart disease and stroke Patient decision aid Taking a statin to reduce the risk of coronary heart disease and stroke http://www.nice.org.uk/guidance/cg181/resources/cg181-lipid-modification-update-patient-decisionaid2 Published:

More information

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014 JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates January 30, 2014 GOALS Review key recommendations from recently published guidelines on blood pressure and cholesterol management Discuss

More information

New Cholesterol Treatment Guidelines. Charles F. Dahl, MD, FACC Cardiologist and Lipidologist, Central Utah Clinic

New Cholesterol Treatment Guidelines. Charles F. Dahl, MD, FACC Cardiologist and Lipidologist, Central Utah Clinic New Cholesterol Treatment Guidelines Charles F. Dahl, MD, FACC Cardiologist and Lipidologist, Central Utah Clinic Objectives: List the 4 treatment groups under the new guidelines Identify how to calculate

More information

High Cholesterol (Dyslipidemia)

High Cholesterol (Dyslipidemia) High Cholesterol (Dyslipidemia) What is high cholesterol? Cholesterol is a type of fat that is found in every cell in the body. It is used to build healthy cells and some vital hormones. High levels of

More information

Who Should Take Statins?

Who Should Take Statins? May 2007 The McDougall Newsletter www.drmcdougall.com Page 1 Who Should Take Statins? Cholesterol-lowering medications, commonly referred to as statins, are considered so beneficial that some enthusiastic

More information

Shared Decision Making

Shared Decision Making Deciding what to do about high cholesterol This short decision aid is to help you decide what to do about your high cholesterol. You can use it on your own, or with your doctor, to help you make a decision

More information

HANDBOOKS for HEALTH MANAGING CHOLESTEROL

HANDBOOKS for HEALTH MANAGING CHOLESTEROL HANDBOOKS for HEALTH MANAGING CHOLESTEROL WELCOA s Handbooks for Health target health problems that need the most attention. EDUCATE YOUR EMPLOYEES WELCOA s Handbooks for Health target health problems

More information

AHA/ASA Guidelines on Prevention of Recurrent Stroke

AHA/ASA Guidelines on Prevention of Recurrent Stroke AHA/ASA Guidelines on Prevention of Recurrent Stroke MARA LAMBERT Guideline source: American Heart Association/American Stroke Association Evidence rating system used? Yes Literature search described?

More information

Cholesterol made simple!

Cholesterol made simple! Cholesterol made simple! Cholesterol is the biggest risk factor for heart disease and also increases your risk of stroke and circulatory disease - Heart UK The Cholesterol Charity What is Cholesterol and

More information

Statins patient decision aid

Statins patient decision aid Statins patient decision aid What this decision aid is for This decision aid is intended to assist health professionals in consultations with patients in whom treatment with a statin is being considered,

More information

moderately elevated triglycerides, e.g. 2 4 mmol/l low protective HDL-cholesterol, e.g mmol/l

moderately elevated triglycerides, e.g. 2 4 mmol/l low protective HDL-cholesterol, e.g mmol/l Chapter 14 Hyperlipidaemia Hyperlipidaemia in diabetes is common. Hypercholesterolaemia confers a 2 3-fold increased coronary heart disease risk in the diabetic compared with the non-diabetic patient at

More information

Lifestyle Management of Hypertension and Dyslipidemia

Lifestyle Management of Hypertension and Dyslipidemia Lifestyle Management of Hypertension and Dyslipidemia Adam Bernstein, MD ScD Director of Research, Wellness Institute Cleveland Clinic 1 2 Outline Current lifestyle management recommendations for hypertension

More information

REACH Risk Evaluation to Achieve Cardiovascular Health

REACH Risk Evaluation to Achieve Cardiovascular Health Dyslipidemia and type 1 diabetes mellitus History: A 15-year-old girl is seen in the endocrinology clinic for a routine follow-up visit for type 1 diabetes. She was diagnosed with diabetes at 12 years

More information

JNC 8 & Cholesterol 11/12/2014 NCEP-III. Where d those target LDLs come from? Lessons from Zetia. It s all about that bass dose!

JNC 8 & Cholesterol 11/12/2014 NCEP-III. Where d those target LDLs come from? Lessons from Zetia. It s all about that bass dose! JNC 8 & Cholesterol NCEP-III Count up the risk factors Goal LDL based on risk factors Titrate statin up to achieve goal We can get through it together LaDonna Hale, PharmD Wichita State University Where

More information

Coronary heart disease

Coronary heart disease COVER ARTICLE Cholesterol Treatment Guidelines Update RICHARD S. SAFEER, M.D., Concentra Medical Centers, Baltimore, Maryland PRABHA S. UGALAT, M.P.H., George Washington University School of Medicine,

More information

High Cholesterol and Heart Disease

High Cholesterol and Heart Disease Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Contents 2: Our recommendations 4: Welcome 7: Who should take a statin drug? 10: Choosing

More information

PRESCRIBING INFORMATION Refer to Summary of Product Characteristics (SmPC) before Prescribing

PRESCRIBING INFORMATION Refer to Summary of Product Characteristics (SmPC) before Prescribing EZETROL (ezetimibe) PRESCRIBING INFORMATION Refer to Summary of Product Characteristics (SmPC) before Prescribing Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

More information

Summary of Product Characteristics

Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Trimega 1000 mg Capsules Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 1000 mg Omega-3-acid ethyl esters 90, comprising

More information

Statin Template Guidance Use of statins in primary and secondary prevention of vascular disease Endorsed by ABHB MTC for use in Gwent (October 2012)

Statin Template Guidance Use of statins in primary and secondary prevention of vascular disease Endorsed by ABHB MTC for use in Gwent (October 2012) Statin Template Guidance Use of statins in primary and secondary prevention of vascular disease Endorsed by ABHB MTC for use in Gwent (October 2012) Notes relating to this guidance This guidance serves

More information

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Read this Patient Information carefully before you start taking VYTORIN and each time you get a refill. There may be new information.

More information

WorkSmart WorkSmart myhealth WorkSmart A1C LDL TrigLyCeriDes CoTinine ToTAL hdl ToTAL ChoLesTeroL ChoLesTeroL-hDL ratio

WorkSmart WorkSmart myhealth WorkSmart A1C LDL TrigLyCeriDes CoTinine ToTAL hdl ToTAL ChoLesTeroL ChoLesTeroL-hDL ratio is designed for the workplace looking for a single, comprehensive set of tests that establish baseline laboratory values for wellness and disease management programs. The Test Package describes the normal

More information

Cholesterol. Richard Cleve Medical Biochemist C.J. Coady Associates

Cholesterol. Richard Cleve Medical Biochemist C.J. Coady Associates Cholesterol Richard Cleve Medical Biochemist C.J. Coady Associates Overview What is cholesterol? What is it? Why is it bad? HO CH 3 1 2 The sample What do we Need to watch For? H 3 C CH 3 3 4 Future H

More information

SEDICO Newsletter Volume 7 Omega-3 Fatty Acids & Statins

SEDICO Newsletter Volume 7 Omega-3 Fatty Acids & Statins Omega-3 fatty acids on heart function (including anti-arrhythmic effects), hemo-dynamics (cardiac mechanics) and arterial endothelial function. The link between omega-3 fatty acids and CVD risk reduction

More information

Individual Study Table Referring to Part of Dossier: Volume: Page:

Individual Study Table Referring to Part of Dossier: Volume: Page: 2.0 Synopsis AbbVie Inc. Name of Study Drug: Trilipix (ABT-335) Name of Active Ingredient: choline salt of fenofibric acid Individual Study Table Referring to Part of Dossier: Volume: Page: (For National

More information

2012 CCS Dyslipidemia Guidelines Update

2012 CCS Dyslipidemia Guidelines Update 1 Agenda Introduction Who to screen & risk assessment Levels of Risk Secondary testing Behavioural recommendation Statin intolerance 2 Changes since 2009 GRADE recommendations Addition of CKD definitions

More information

Hyperlipidemia Management Protocol STANFORD COORDINATED CARE

Hyperlipidemia Management Protocol STANFORD COORDINATED CARE PURPOSE: To enhance collaborative patient care by referral of patients with a diagnosis of dyslipidemia, coronary artery disease (CAD), diabetes (DM) or is at high risk for coronary heart disease to be

More information

HEMOGLOBIN Hemoglobin measures the protein found in a red blood cell. It contains iron and carries oxygen from lungs to body tissues.

HEMOGLOBIN Hemoglobin measures the protein found in a red blood cell. It contains iron and carries oxygen from lungs to body tissues. WBC 4.00-10.50 WBC measures the total number of white blood cells in a given volume of blood. Since white blood cells kill bacteria, this count is a measure of the body s response to infection. In general,

More information

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.

More information

ABOUT HIGH CHOLESTEROL AND HIGH TRIGLYCERIDES

ABOUT HIGH CHOLESTEROL AND HIGH TRIGLYCERIDES ABOUT HIGH CHOLESTEROL AND HIGH TRIGLYCERIDES Because the more you know, the healthier you can be. This booklet is designed to help you understand high cholesterol and high triglycerides (called lipids

More information

Who typically has Metabolic Syndrome? According to the American Heart Association, three groups of people often have metabolic syndrome:

Who typically has Metabolic Syndrome? According to the American Heart Association, three groups of people often have metabolic syndrome: Metabolic Syndrome By Seth Bilazarian, MD, FACC, FSCAI, RPVI Clinical and Intervential Cardiologist What is the Metabolic Syndrome? The Metabolic Syndrome is a collection of five problems that greatly

More information

Cholesterol and your Heart. Public Information Pamphlets

Cholesterol and your Heart. Public Information Pamphlets Cholesterol and your Heart Public Information Pamphlets CHOLESTEROL AND YOUR HEART Cholesterol is naturally present in the body and is an essential substance. It is only when levels of Cholesterol rise

More information

Non-HDL Cholesterol: When and How to Treat

Non-HDL Cholesterol: When and How to Treat September 01, 2008 By Edward J. Shahady, MD [1] Over the past 4 decades, our understanding of the role of elevated cholesterol in cardiovascular disease (CVD) has undergone radical change. During that

More information

Managing High Cholesterol with Heart360

Managing High Cholesterol with Heart360 Managing High Cholesterol with Heart360 For Healthcare Providers and Their Patients rev 11/2014 Managing High Cholesterol with Heart360 For Healthcare Providers and Their Patients Communicating with Your

More information

Overview. Nutritional Aspects of Primary Biliary Cirrhosis. How does the liver affect nutritional status?

Overview. Nutritional Aspects of Primary Biliary Cirrhosis. How does the liver affect nutritional status? Overview Nutritional Aspects of Primary Biliary Cirrhosis Tracy Burch, RD, CNSD Kovler Organ Transplant Center Northwestern Memorial Hospital Importance of nutrition therapy in PBC Incidence and pertinence

More information

I The THREE types of LIPIDS

I The THREE types of LIPIDS LECTURE OUTLINE Chapter 5 The Lipids: Fats, Oils, Phospholipids and Sterols I The THREE types of LIPIDS A. Triglycerides (fats & oils)- the MAJOR type of lipid in food and humans. 1. 2 parts of triglyceridesa)

More information

10/11/2014. Laura C. Halder, Pharm.D. Postgraduate Year Two Pharmacy Resident Cardiology Abbott Northwestern Hospital Allina Health October 30, 2014

10/11/2014. Laura C. Halder, Pharm.D. Postgraduate Year Two Pharmacy Resident Cardiology Abbott Northwestern Hospital Allina Health October 30, 2014 Laura C. Halder, Pharm.D. Postgraduate Year Two Pharmacy Resident Cardiology Abbott Northwestern Hospital Allina Health October 30, 2014 1 1. List two major changes to the 2013 cholesterol treatment guidelines.

More information

Lipid-lowering: Can ezetimibe help close the treatment gap?

Lipid-lowering: Can ezetimibe help close the treatment gap? REVIEW CME CREDIT RYAN C. NEAL, MD* Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas PETER H. JONES, MD Associate Professor of Medicine, Baylor College of Medicine, Houston,

More information

Why Should I Care About Drug Interactions? Karen Kopacek RPh Clinical Assistant Professor, UW School of Pharmacy; Clinical Pharmacist, UWHC

Why Should I Care About Drug Interactions? Karen Kopacek RPh Clinical Assistant Professor, UW School of Pharmacy; Clinical Pharmacist, UWHC Why Should I Care About Drug Interactions? Karen Kopacek RPh Clinical Assistant Professor, UW School of Pharmacy; Clinical Pharmacist, UWHC Objectives Describe the absorption, distribution, metabolism,

More information

Other commonly known names of vitamin A include Retinol, Retinal, Retinoic acid and Carotenoids.

Other commonly known names of vitamin A include Retinol, Retinal, Retinoic acid and Carotenoids. Medical Nutrition Therapy Nutrient: Vitamin A 1. What is the nutrient? Vitamin A is a fat-soluble group of retinoids including retinol, retinal, retinoic acid and retinyl esters. Vitamin A is involved

More information

Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health

Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health Position statement Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health Updated November 2008 This position statement was developed to provide recommendations to the general population

More information

Hyperlipidemia and Atherosclerosis 2005 Robert S. Lees, M.D.

Hyperlipidemia and Atherosclerosis 2005 Robert S. Lees, M.D. Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Dr. Robert Lees 1 BACKGROUND Hyperlipidemia and Atherosclerosis 2005 Robert S. Lees, M.D. I. Atherosclerosis:

More information

Management of Lipids in 2015: Just Give them a Statin?

Management of Lipids in 2015: Just Give them a Statin? Management of Lipids in 2015: Just Give them a Statin? James H. Stein, M.D. Division of Cardiovascular Medicine University of Wisconsin School of Medicine and Public Health Stone NJ, et al. Circulation

More information

Cardiovascular Disease Risk Factors

Cardiovascular Disease Risk Factors Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or

More information

Medication Therapy for Heart Disease. Bhamini Patel, PharmD, BCPS Clinical Pharmacist

Medication Therapy for Heart Disease. Bhamini Patel, PharmD, BCPS Clinical Pharmacist Medication Therapy for Heart Disease Bhamini Patel, PharmD, BCPS Clinical Pharmacist Objectives Review Conditions that affect the Heart High Blood Pressure, Hyperlipidemia and Diabetes Review Medications

More information

Rx Updates New Guidelines, New Medications What You Need to Know

Rx Updates New Guidelines, New Medications What You Need to Know Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact

More information

Prescribing Information

Prescribing Information The format of this leaflet was determined by the Ministry of Health and its content was checked and approved by it. Omacor Prescribing Information 1 NAME OF THE MEDICINAL PRODUCT OMACOR, 1000 mg, soft

More information

Pediatric Metabolic Syndrome

Pediatric Metabolic Syndrome University of Michigan Hospitals and Health Centers Pediatric Metabolic Syndrome A growing epidemic Shannon Russell Dietetic Intern June 2012 Overview Causes Risk Factors Signs and Symptoms Identification/Diagnosis

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information